IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival

Type 2 innate lymphoid cells (ILC2s) are a subset of ILCs with critical roles in immunoregulation. However, the possible role of ILC2s as immunotherapy against allograft rejection remains unclear. Here, we show that IL‐33 significantly prolonged islet allograft survival. IL‐33‐treated mice had eleva...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EMBO Mol Med
Huvudupphovsmän: Huang, Qingsong, Ma, Xiaoqian, Wang, Yiping, Niu, Zhiguo, Wang, Ruifeng, Yang, Fuyan, Wu, Menglin, Liang, Guining, Rong, Pengfei, Wang, Hui, Harris, David CH, Wang, Wei, Cao, Qi
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645373/
https://ncbi.nlm.nih.gov/pubmed/33034128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012305
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk